Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Cohort 1 – Obesity group:
- Adults aged 18 to 65 years old
- A body mass index (BMI) of 30 or higher, which is generally considered the obesity range
- Must be a patient at Franciscus Hospital
Cohort 2 – Comparison group:
- Adults aged 18 to 65 years old
- A BMI below 25, which is generally considered a healthy weight range
- Must be a healthcare worker at Franciscus Hospital
Who may not be able to join:
- People who currently have an active infection or an ongoing condition where the immune system attacks the body (such as an autoimmune disease)
- People who are currently taking medications that affect how the immune system works, such as steroids or biological drugs
- People who are currently using hormonal therapy
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David S.Y. Ong, M.D., Ph.D., Pharm.D., M.Sc., Franciscus Hospital
Phone: +316 40897778
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The concentration of pro-inflammatory cytokines (IL-6, IL-1β, and TNF) produced by macrophages upon both SARS-CoV-2 viral and antibody costimulation.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.